|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kepone |
CAS 143-50-0 | ||
C10Cl10O |
RTECS PC8575000 | ||
|
Synonyms & Trade Names Chlordecone; Decachlorooctahydro-1,3,4-metheno-2H-cyclobuta(cd)-pentalen-2-one; Decachlorooctahydro-kepone-2-one; Decachlorotetrahydro-4,7-methanoindeneone |
DOT ID & Guide |
||
Exposure
|
NIOSH REL: Ca TWA 0.001 mg/m3 See Appendix A | ||
| OSHA PEL: none | |||
| IDLH Ca [N.D.] See: IDLH INDEX | Conversion | ||
|
Physical Description Tan to white, crystalline, odorless solid. [insecticide] |
|||
|
MW: 490.6 |
BP: Sublimes |
MLT: 662°F (Sublimes) |
Sol(212°F): 0.5% |
|
VP(77°F): 3 x 10-7 mmHg |
IP: ? |
|
Sp.Gr: ? |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid | |||
|
Incompatibilities & Reactivities Acids, acid fumes |
|||
|
Measurement Methods NIOSH 5508 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Headache, anxiety, tremor; liver, kidney damage; visual disturbance; ataxia, chest pain, skin erythema (skin redness); testicular atrophy, low sperm count; [potential occupational carcinogen] | |
|
Target Organs
Eyes, skin, respiratory system, central nervous system, liver, kidneys, reproductive system Cancer Site [in animal: liver cancer] |
|
| See also: INTRODUCTION |